Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancers|February 13, 2025
Patient-Derived Organoid Models for NKT Cell-Based Cancer ImmunotherapyPablo A Palacios, Iván Flores, Lucas Cereceda, et al.
Cancers|December 23, 2023
Natural Killer T Cell Diversity and ImmunotherapyEduardo I Tognarelli, Cristián Gutiérrez-Vera, Pablo A Palacios, et al.
Frontiers in Immunology|March 5, 2025
Can invariant Natural Killer T cells drive B cell fate? a look at the humoral responsePablo A Palacios, Álvaro Santibañez, Fernanda Aguirre-Muñoz, et al.
Frontiers in Immunology|August 14, 2023
A chimeric protein-based vaccine elicits a strong IgG antibody response and confers partial protection against Shiga toxin-producing <i>Escherichia coli</i> in miceDavid A Montero, Richard Garcia-Betancourt, Roberto M Vidal, et al.
Frontiers in Immunology|April 17, 2024
Natural killer T cells in allergic asthma: implications for the development of novel immunotherapeutical strategiesCristián Gutiérrez-Vera, Richard García-Betancourt, Pablo A Palacios, et al.
Frontiers in Cellular and Infection Microbiology|September 27, 2023
Contribution of viral and bacterial infections to senescence and immunosenescenceAntonia Reyes, Gerardo Ortiz, Luisa F Duarte, et al.
BMC Medicine|December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunityConstanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.
Nature Communications|December 7, 2025
Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trialLinmar Rodríguez-Guilarte, Constanza Méndez, Antonia Reyes, et al.
Mbio|November 16, 2022
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in ChildrenJorge A Soto, Felipe Melo-González, Cristián Gutierrez-Vera, et al.
Pageof 1